(2024) Quantification of the Cellular Content of Platelet Rich Plasma Harvested After Injection of Filgrastim Versus Pegfilgrastim Biosimilars: A Prospective, Single Center, Crossover Study

The purpose of this study was to determine if different medications would stimulate changes in the content of a patient’s blood used for platelet-rich plasma injections.

External Collaborators: Mohammadreza Abbasian, Eric Branch, Ali Parsa, Jessica Truett, Joshua J. Cook, Charlkesha A. Rahming, and Adam W. Anz.

Partner Institutions: Andrews Institute Center for Regenerative Medicine